Finally, a recent study in human breast cancer cells has shown that mortalin supports breast cancer stem cells and enhances EMT through activation of the Wnt/GSK3β/β-catenin signaling pathway (Wei et al., 2021). The gene discussed is HSPA9; the disease is breast carcinoma.